EcoDrugPlus

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSSVLG00005023635
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSSVLG00005001470
Gene Symbol: DPYD
1 Cross references
220 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSSVLG00005013198
Gene Symbol: DPP4
1 Cross references
282 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSSVLG00005005804
Gene Symbol: DDR2
1 Cross references
265 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSSVLG00005012085
Gene Symbol: DRD1
1 Cross references
261 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSSVLG00005018544
Gene Symbol: DRD2
1 Cross references
219 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSSVLG00005012723
Gene Symbol: DRD4
1 Cross references
246 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSSVLG00005007542
Gene Symbol: DRD5
1 Cross references
186 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSSVLG00005002697
Gene Symbol: ENPP2
1 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSSVLG00005010770
Gene Symbol: EGLN1
1 Cross references
231 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSSVLG00005018049
Gene Symbol: EGLN2
1 Cross references
190 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSSVLG00005003108
Gene Symbol: EGLN3
1 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).